Michael J. LaBarre - 15 Nov 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler as attorney-in-fact for Michael J. LaBarre
Issuer symbol
HALO
Transactions as of
15 Nov 2022
Net transactions value
-$541,263
Form type
4
Filing time
16 Nov 2022, 18:25:42 UTC
Previous filing
17 Feb 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale $372,183 -6,877 -4% $54.12 166,260 15 Nov 2022 Direct F1, F2
transaction HALO Common Stock Sale $437 -8 -0% $54.61 166,252 15 Nov 2022 Direct F1
transaction HALO Common Stock Sale $168,643 -3,115 -1.9% $54.14 163,137 15 Nov 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $53.59 to $54.50. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.